$CURLF Cashflow Statement | Understand Stock

$CURLF

$9.92 +$0.45 (4.75%) Close

$CURLF Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net loss
Depreciation and amortization
Share-based compensation
Non-cash interest expense
Unrealized gain on changes in fair value of biological assets
Realized fair value amounts included in inventory sold
Impairment loss
(Gain)/loss on debt retirement
(Gain)/loss on investment
(Gain)/loss on sale of property, plant and equipment
Deferred taxes
Accounts receivable
Biological assets
Inventories
Prepaid expenses and other current assets
Other assets
Accounts payable
Income taxes payable
Accrued expenses
Net cash provided (used) in operating activities
Purchases of property and equipment
Proceeds from sale of entity
Payments made on completion on acquisitions
Cash acquired from acquisitions
Payments received on notes receivable
Note receivable from third party
Net cash used in investing activities
Cash received from financing agreement
Proceeds from sale leaseback
Debt issuance costs
Minority buyouts
Cash flows from operating activities:
Net loss
Net loss from continuing operations
Adjustments to reconcile net loss from continuing operations to net cash provided by operating activities from continuing operations:
Depreciation and amortization
Share-based compensation
Non-cash interest expense
Amortization of operating lease right-of-use assets
Loss on impairment
Gain on extinguishment of debt
Loss (gain) on disposal of assets
Loss (gain) on investment
Non-cash adjustments to inventory
Allowance for credit losses
Deferred taxes
Other non-cash (income) expenses
Payment of contingent consideration liability in excess of acquisition-date fair value
Foreign exchange (gain) loss
Changes in assets and liabilities:
Accounts receivable, net
Inventories, net
Prepaid expenses and other current assets
Income tax receivable
Net assets held for sale
Investments and other assets
Accounts payable
Accrued expenses and other liabilities
Income tax payable
Operating leases, net (right-of-use asset acquisitions and disposals)
Lease liabilities, operating

Net cash provided by operating activities from continuing operations
Net cash used in operating activities from discontinued operations
Net cash provided by operating activities
Cash flows from investing activities:
Purchases of property, plant and equipment
Disposals of property, plant and equipment
Proceeds from sale of entities
Proceeds from consolidation of acquisitions
Acquisition-related cash payments, net of cash acquired
Purchases of intangibles
Purchase of investments
Dividend received on investments
Issuance of notes receivable
Dividend received
Payments received on notes receivables
Net cash used in investing activities from continuing operations
Net cash (used in) provided by investing activities from discontinued operations
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from financing agreement
Proceeds from notes payable
Minority interest investment in Curaleaf International
Proceeds from finance leases and financial obligations
Principal payments on notes payable
Prepayment penalties on retired notes payable
Lease liability payments
Proceeds from minority interest investment in Curaleaf International
Net cash provided by financing activities
Net change in cash
Cash at beginning of period
Effect of exchange rate on cash
Cash at end of period
Cash paid for interest
Cash paid for income tax
Issuance of shares in connection with acquisitions
Cash Paid for EMMAC to former EMMAC owners by Minority Interest Holder
Payments of debt issuance costs
Acquisition escrow shares returned and retired
Minority interest buyouts
Proceeds from sale leasebacks
Proceeds from financing transactions
Principal payments on finance lease liabilities
Principal payments on financial obligations
Remittances of statutory withholdings on share-based payment awards
Forfeiture of restricted stock units
Exercise of stock options
Payments of deferred consideration
Payments of contingent consideration
Issuance of common shares, net of issuance costs
Net cash used in financing activities from continuing operations
Net cash used in financing activities from discontinued operations
Net cash used in financing activities

Net (decrease) increase in cash and cash equivalents (including restricted cash and cash equivalents)
Cash and cash equivalents (including restricted cash and cash equivalents), beginning of period
Effect of exchange rate on cash
Effect of exchange rate changes on cash and cash equivalents (including restricted cash and cash equivalents)
Cash and cash equivalents (including restricted cash and cash equivalents), end of period
Non-cash investing & financing activities:
Purchases of property, plant and equipment within accounts payable and accrued expenses
Issuance of SVS in connection with acquisitions
Non-cash proceeds from Note Exchange (as defined herein)
Extinguishment of convertible notes by issuance of SVS
Non-cash activity related to modification of failed sale and leaseback arrangements
Non-cash activity related to obtaining finance right-of-use assets
Non-cash activity related to obtaining operating right-of-use assets
Other non-cash activity related to finance right-of-use assets
Other non-cash activity related to operating right-of-use assets
Issuance of notes in connection with sale of entities
Cash paid for EMMAC to former EMMAC owners by minority interest holder
Contingent consideration incurred in connection with acquisitions
Redeemable NCI
Equity issuance
Deferred consideration incurred in connection with acquisitions
Failed sale leaseback
Purchase price allocation adjustments
Forgiveness of promissory note in connection with acquisition
Write off of prior debt deferred costs
Redeemable non-controlling interest
Non-cash additions to finance and operating right-of-use assets
SVS contributed to Curaleaf, Inc. in connection with the Reorganization
Settlement of contingent liability through issuance of shares
Recategorization of net assets from held-for-sale to held-and-used
Issuance of SVS for settlement of liability
Excess redemption value attributable to non-controlling interest
Issuance of SVS to purchase non-controlling interest
Excess carrying value of redeemed NCI over consideration paid in SVS
Non-cash reduction to deferred sale proceeds
Non-cash reduction to acquisition-related deferred consideration

Supplemental disclosure of cash flow information:
Cash paid for taxes
Cash paid for interest
Excess tax benefit from exercise of options

Comments